Cited by 1,052Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects

The DOI matches its Crossref record; 64 of the 68 references it cites were found in a registry or an index.

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Glass, M, Faull, R.L.M, Dragunow, M·1997·Neuroscience

DOI 10.1016/s0306-4522(96)00428-9

Open this paper in CoChat — free account

Abstract

The anatomical distribution and density of cannabinoid receptors in the human brain was studied in one fetal (33 weeks gestation), two neonatal (aged three to six months) and eight adult (aged 21-81 years) human cases using quantitative receptor autoradiography following in vitro labelling of sections with the synthetic cannabinoid agonist [3H]CP55,940. Cannabinoid receptors were distributed in a heterogeneous fashion throughout the adult human brain and spinal cord. The allocortex contained very high concentrations of cannabinoid receptor binding sites in the dentate gyrus, Ammons's horn and subiculum of the hippocampal formation; high concentrations of receptors were also present in the entorhinal cortex and amygdaloid complex. Cannabinoid receptor binding sites were also present throughout all regions of the neocortex, where they showed a marked variation in density between the primary, secondary and associational cortical regions: the greatest densities of receptors were present in the associational cortical regions of the frontal and limbic lobes, with moderate densities in the secondary sensory and motor cortical regions, and with the lowest densities of receptors in the primary sensory and motor cortical regions. Relatively high concentrations of cannabinoid receptors were consistently seen in cortical regions of the left (dominant) hemisphere, known to be associated with verbal language functions. In all of the cortical regions, the pattern and density of receptor labelling followed the neocortical laminar organization, with the greatest density of receptors localized in two discrete bands--a clearly delineated narrow superficial band which coincided with lamina I and a deeper broader, conspicuous band of labelling which corresponded to laminae V and VI. Labelling in the intervening cortical laminae (II-IV) showed lower densities, with a well delineated narrow band of label in the middle of laminae IV in the associational cortical regions. The thalamus showed a distinctive heterogeneous distribution of cannabinoid receptors, with the highest concentration of receptors localized in the mediodorsal nucleus, anterior nuclear complex, and in the midline and intralaminar complex of nuclei, i.e. in thalamic nuclei which have connectional affiliations with the associational cortical areas. The basal ganglia showed a distinctive heterogeneous pattern of receptor binding, with the very highest concentrations in the globus pallidus internus, moderate concentrations in the globus pallidus externus and ventral pallidum, and moderately low levels of binding throughout the striatal complex. In the midbrain, some of the highest levels of cannabinoid receptor binding sites in the human brain were present in the substantia nigra pars reticulata, with very low levels of labelling in all other midbrain areas. The highest densities of cannabinoid receptor binding in the hindbrain were localized in the molecular layer of the cerebellar cortex and the dorsal motor nucleus of the vagus, with moderate densities of receptors in the nucleus of the solitary tract. The spinal cord showed very low levels of receptor binding. Studies on the distribution of cannabinoid receptors in the fetal and neonatal human brain showed similar patterns of receptor distribution to that observed in the adult human brain, except that the density of receptor binding was generally markedly higher, especially in the basal ganglia and substantia nigra. The pattern of cannabinoid receptor labelling in the striatum showed a striking patchy pattern of organization which was especially conspicuous in the fetal brain. These results show that cannabinoid receptor binding sites in the human brain are localized mainly in: forebrain areas associated with higher cognitive functions; forebrain, midbrain and hindbrain areas associated with the control of movement; and in hindbrain areas associated with the control of motor and sensory functions of the autonomic nervous system. (AB

Integrity signals

Registry

Crossref · 10.1016/s0306-4522(96)00428-9

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The Thalamus
Jones, E. G. (1985) · Springer eBooks · doi:10.1007/978-1-4615-1749-8 · Cited by 1,164
Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784
Laminar Organization of Thalamic Projections to the Rat Neocortex
Herkenham, M. A. (1980) · Science · doi:10.1126/science.7352263 · Cited by 595
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Health aspects of cannabis
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500

Show all 68 references

Research works printed but not linked: 9

Bidaut-Russell, 1989, Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum, Adv. Biosci., 75, 165
Campbell, 1986, Delta-9-tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat detate gyrus, J. Pharmac. exp. Ther., 239, 941
Chen, 1993, Transient concentration of cannabinoid receptors in the cortex subplate zone during kitten post-natal development, Soc. Neurosci. Abstr., 19, 305
Devane, 1988, Determination and characterisation of a cannabinoid receptor in rat brain, Molec. Pharmac., 34, 605
Dewey, 1972, The effects of chronic administration of trans-delta-9-tetrahydorcannibinol on behaviour and the cardiovascular system of dogs, Archs int. Pharmacodyn. Thér., 198, 118
Edery, 1972, Structure activity relationships in the tetrahydrocanabinol species, Arzneimittel-Forshch., 22, 1995
Howlett, 1985, Cannabinoid inhibition of adenylate cyclase. Biochemistry of response in neuroblasta cell membrane, Molec. Pharmac., 27, 429
Howlett, 1986, Involvement of Gi in the inhibition of adenylate cyclase by cannabinoid drugs, Molec. Pharmac., 29, 307
Mendelson, 1976, Operant acquisition of marijuana by men, J. Pharmac. exp. Ther., 198, 42

Sorted by citations

Items 601–700 of 1,000

Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type‐1 receptors in vivo
Finnema, S. J., Donohue, S. R., Zoghbi, S. S., Brown, A. K., Gulyás, B. Z., Innis, R. B., Halldin, C., & Pike, V. W. (2008) · Synapse · doi:10.1002/syn.20578 · Cited by 17
Ruthenium-Mediated 18F-Fluorination and Preclinical Evaluation of a New CB1 Receptor Imaging Agent [18F]FPATPP
Lahdenpohja, S., Rajala, N., Helin, J. S., Haaparanta‐Solin, M., Solin, O. H., Lopez‐Picon, F. R., & Kirjavainen, A. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00313 · Cited by 17
Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches
Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 21
Neonatal Intensive Care Unit Network Neurobehavioral Scale Profiles in Full-Term Infants: Associations with Maternal Adversity, Medical Risk, and Neonatal Outcomes
Parikh, A. N., Triplett, R. L., Wu, T., Arora, J. K., Lukas, K., Smyser, T. A., Miller, J. P., Luby, J. L., Rogers, C. E., Barch, D. M., et al. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.04.016 · Cited by 17
Is there a role for palmitoylethanolamide in the treatment of depression?
Coppola, M., & Mondola, R. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2013.12.016 · Cited by 19
Sphingosine lysolipids in the CNS: Endogenous cannabinoid antagonists or a parallel pain modulatory system?
Selley, D. E., Welch, S. P., & Sim‐Selley, L. J. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.06.004 · Cited by 17
Effects of Cannabinoids on Caffeine Contractures in Slow and Fast Skeletal Muscle Fibers of the Frog
Huerta, M., Ortiz, M., Trujillo, X., Sánchez-Pastor, E. A., Vásquez, C., Castro, E., Velasco, R., Montoya-Pérez, R. D. C., & Onetti, C. G. (2009) · The Journal of Membrane Biology · doi:10.1007/s00232-009-9174-4 · Cited by 17
Neurotoxicology and drug-related disorders
Weis, S., & Büttner, A. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00014-6 · Cited by 17
The Cannabinoid Receptor Agonist WIN 55212-2 Inhibits Neurogenic Inflammations in Airway Tissues
Yoshihara, S., Morimoto, H., Ohori, M., Yamada, Y., Abe, T., & Arisaka, O. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050171 · Cited by 17
Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens
Kucera, R., Bouskila, J., Elkrief, L., Fink‐Jensen, A., Palmour, R. M., Bouchard, J., & Ptito, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-26826-2 · Cited by 16
Neuroanatomical alterations in people with high and low cannabis dependence
Lorenzetti, V., Chye, Y., Suo, C., Walterfang, M., Lubman, D. I., Takagi, M., Whittle, S., Verdejo‐García, A., Cousijn, J., Pantelis, C., et al. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419859077 · Cited by 16
Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives
Ferber, S. G., Hazani, R., Shoval, G., & Weller, A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200429234430 · Cited by 16
Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders
Lopresti, B. J., Royse, S. K., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15615 · Cited by 16
A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates
Hjorth, S., Karlsson, C., Jučaitė, A., Varnäs, K., Hamrén, U. W., Johnström, P., Gulyás, B. Z., Donohue, S. R., Pike, V. W., Halldin, C., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.002 · Cited by 16
Lower Left Thalamic Myo-Inositol Levels Associated with Greater Cognitive Impulsivity in Marijuana-Dependent Young Men: Preliminary Spectroscopic Evidence at 4T
Mashhoon, Y. (2013) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s4-009 · Cited by 16
Evaluation of the profiles of CB1 cannabinoid receptor signalling bias using joint kinetic modelling
Zhu, X., Finlay, D. B., Glass, M., & Duffull, S. B. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15066 · Cited by 16
Self-citation
Pharmacologie des dérivés cannabinoïdes : applications au traitement de la douleur ?
Beaulieu, P., & Rice, A. S. C. (2002) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(02)00663-9 · Cited by 16
Central Nervous System Alterations in Drug Abuse
Büttner, A., & Weis, S. (2004) · Forensic pathology reviews · doi:10.1007/978-1-59259-786-4_4 · Cited by 16
Functional Organization of Dorsal Horn Interneurons
Willis, W. D., & Coggeshall, R. E. (2004) · Springer eBooks · doi:10.1007/978-1-4615-0037-7_7 · Cited by 16
Cannabis
(1998) · CRC Press eBooks · doi:10.1201/9780203304228 · Cited by 16
Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development
Scott, J. C. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.06.002 · Cited by 16
An investigation of the relationship between glutamate and resting state connectivity in chronic cannabis users
Newman, S. D., Cheng, H., Kim, D., Martin, A. M. S., Dydak, U., Dharmadhikari, S., Hetrick, W. P., & O’Donnell, B. F. (2019) · Brain Imaging and Behavior · doi:10.1007/s11682-019-00165-w · Cited by 15
An Investigation of Neurochemical Changes in Chronic Cannabis Users
Newman, S. D., Cheng, H., Martin, A. M. S., Dydak, U., Dharmadhikari, S., Hetrick, W. P., & O’Donnell, B. F. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00318 · Cited by 15
Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders
Song, C., Kang, X., Yang, F., Du, W., Zhang, J., Liu, L., Kang, J., Jia, N., Yue, H., Fan, L., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0134 · Cited by 15
Interactions between cannabinoid and opioid receptors in a mouse model of diabetic neuropathy
Toniolo, E. F., Gupta, A., Franciosi, A. C., Gomes, I., Devi, L. A., & Dale, C. S. (2021) · Pain · doi:10.1097/j.pain.0000000000002527 · Cited by 15
Delineating the interactions between the cannabinoid CB2 receptor and its regulatory effectors; β‐arrestins and GPCR kinases
Patel, M., Matti, C., Grimsey, N. L., Legler, D. F., Javitch, J. A., Finlay, D. B., & Glass, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15748 · Cited by 15
Self-citation
Adverse Effects of Cannabis
(2018) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(18)30087-5 · Cited by 15
Effects on Development
Ramos, J. A., Gómez, M., & de Miguel, R. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_22 · Cited by 15
Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors
Donohue, S. R., Varnäs, K., Jia, Z., Gulyás, B. Z., Pike, V. W., & Halldin, C. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.092 · Cited by 15
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures
Antonelli, T., Tomasini, M. C., Tattoli, M., Cassano, T., Finetti, S., Mazzoni, E., Trabace, L., Carratù, M. R., Cuomo, V., & Tanganelli, S. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.012 · Cited by 15
Examining Inhibitory Affective Processing Within the Rostral Anterior Cingulate Cortex Among Abstinent Cannabis-Using Adolescents and Young Adults
Sullivan, R. M., Maple, K. E., Wallace, A. L., Thomas, A. M., & Lisdahl, K. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.851118 · Cited by 16
Acute cannabis intoxication among the paediatric population
Malta, G., Albano, G. D., Lavanco, G., Brancato, A., Cannizzaro, C., Argo, A., Contorno, S., Plescia, F., & Zerbo, S. (2025) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1558721 · Cited by 16
History of Cannabis as Medicine: Nineteenth Century Irish Physicians and Correlations of Their Observations to Modern Research
Russo, E. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-54564-6_2 · Cited by 14
Undesired Plant-Derived Components in Food
Dusemund, B., Rietjens, I. M. C. M., Abraham, K., Cartus, A. T., & Schrenk, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100674-0.00016-3 · Cited by 14
Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat
Perez, S. M., Donegan, J. J., Boley, A. M., Aguilar, D. D., Giuffrida, A., & Lodge, D. J. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.11.006 · Cited by 14
Energy sensors in drug addiction: A potential therapeutic target
López-Gambero, A. J., de Fonseca, F. R., & Suárez, J. (2020) · Addiction Biology · doi:10.1111/adb.12936 · Cited by 14
Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis
Bortolato, M., Bini, V., & Tambaro, S. (2010) · Pharmaceuticals · doi:10.3390/ph3092799 · Cited by 17
Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists
Patel, M., Zheng, X., Akinfiresoye, L. R., Prioleau, C., Walker, T. D., Glass, M., & Marusich, J. A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176549 · Cited by 13
Self-citation
Peripherally restricted cannabinoid and mu-opioid receptor agonists synergistically attenuate neuropathic mechanical hypersensitivity in mice
Limerick, G., Uniyal, A., Ford, N. C., He, S.-Q., Grenald, S. A., Zhang, C., Cui, X., Sivanesan, E., Dong, X., Guan, Y., et al. (2024) · Pain · doi:10.1097/j.pain.0000000000003278 · Cited by 13
Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders
Basavarajappa, B. S., & Subbanna, S. (2024) · Biomolecules · doi:10.3390/biom14101296 · Cited by 14
Maternal Immune Activation and the Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia
Santoni, M., & Pistis, M. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.11.015 · Cited by 13
Cannabidiol alters psychophysiological, craving and anxiety responses in an alcohol cue reactivity task: A cross‐over randomized controlled trial
Hurzeler, T. P., Logge, W., Watt, J., McGregor, I. S., Suraev, A. S., Haber, P., & Morley, K. C. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15514 · Cited by 13
Dyskinesias in Parkinson's disease: views from positron emission tomography studies
Niccolini, F., Loane, C., & Politis, M. (2014) · European Journal of Neurology · doi:10.1111/ene.12362 · Cited by 13
Developing a phone-based measure of impairment after acute oral ∆ 9 -tetrahydrocannabinol
Pabon, E., & de Wit, H. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119862533 · Cited by 13
Reduction in hippocampal volumes subsequent to heavy cannabis use: a 3-year longitudinal study
Wang, Y., Zuo, C., Wang, W., Xu, Q., & Lei, H. C. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113588 · Cited by 13
The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents
Skumlien, M., Freeman, T. P., Hall, D., Mokrysz, C., Wall, M. B., Ofori, S., Petrilli, K., Trinci, K., Borissova, A., Fernandez‐Vinson, N., et al. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.10.004 · Cited by 13
Design, synthesis, and structure–activity relationships of diindolylmethane derivatives as cannabinoid CB2 receptor agonists
Mahardhika, A. B., Ressemann, A., Kremers, S., Castanheira, M. S. G., Schoeder, C. T., Müller, C. E., & Pillaiyar, T. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200493 · Cited by 13
Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis
Buchy, L., Mathalon, D. H., Cannon, T. D., Cadenhead, K. S., Cornblatt, B. A., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Walker, E. F., et al. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.06.001 · Cited by 13
Cannabis Use and Psychiatric Disorders: Implications for Mental Health and Addiction Treatment
Halah, M. P., Zochniak, M. P., Barr, M. S., & George, T. P. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0128-5 · Cited by 13
Distribution of the Cannabinoid Receptor Type 1 in the Brain of the Genetically Audiogenic Seizure-Prone Hamster GASH/Sal
Fuerte-Hortigón, A., Gonçalves-Sánchez, J., Zeballos, L., Masa, R., Gómez‐Nieto, R., & López, D. E. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.613798 · Cited by 16
Future of Cannabis and Cannabinoids in Therapeutics
Russo, E. B. (2004) · Journal of Cannabis Therapeutics · doi:10.1300/j175v03n04_04 · Cited by 13
Involvement of medial prefrontal cortex alpha-2 adrenoceptors on memory acquisition deficit induced by arachidonylcyclopropylamide, a cannabinoid CB 1 receptor agonist, in rats; possible involvement of Ca 2+ channels
Beiranvand, A., Nasehi, M., Zarrindast, M., & Moghaddasi, M. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116652585 · Cited by 13
Altered cerebellar-cortical resting-state functional connectivity in cannabis users
Martin, A. M. S., Kim, D., Newman, S. D., Cheng, H., Hetrick, W. P., Mackie, K., & O’Donnell, B. F. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211019291 · Cited by 13
Cannabinoid suppressed bicuculline-induced convulsion without respiratory depression in the brainstem-spinal cord preparation from newborn rats
Shusuke, K. O. D. A., Takeda, S., Onimaru, H., Akada, S., & Sakamoto, A. (2005) · Biomedical Research · doi:10.2220/biomedres.26.241 · Cited by 13
Altered amygdala-cortical connectivity in individuals with Cannabis use disorder
Aloi, J. M., McCusker, M. C., Lew, B. J., Schantell, M. D., Eastman, J. A., Frenzel, M. R., & Wilson, T. W. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211054163 · Cited by 12
The Potential Mechanism of Cannabidiol (CBD) Treatment of Epilepsy in Pentetrazol (PTZ) Kindling Mice Uncovered by Multi-Omics Analysis
Lu, H., Wang, Q., Jiang, X., Zhao, Y., He, M., & Wei, M. (2023) · Molecules · doi:10.3390/molecules28062805 · Cited by 12
Longitudinal associations between amygdala reactivity and cannabis use in a large sample of adolescents
Spechler, P. A., Chaarani, B., Orr, C., Albaugh, M. D., Fontaine, N. R., Higgins, S. T., Banaschewski, T., Bokde, A. L. W., Quinlan, E. B., Desrivières, S., et al. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05624-7 · Cited by 12
Risky decision‐making as an antecedent or consequence of adolescent cannabis use: findings from a 2‐year longitudinal study
Pacheco‐Colón, I., Lopez‐Quintero, C., Coxe, S. J., Limia, J. M., Pulido, W. J., Granja, K., Paula, D. C., González, I., Ross, J. M., Duperrouzel, J. C., et al. (2021) · Addiction · doi:10.1111/add.15626 · Cited by 12
Astroglial cannabinoid signaling and behavior
Ramon‐Duaso, C., Conde-Moro, A. R., & Busquets-García, A. (2022) · Glia · doi:10.1002/glia.24171 · Cited by 13
Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study
Sorkhou, M., Rabin, R. A., Rabin, J. S., Kloiber, S. M., McIntyre, R. S., & George, T. P. (2022) · American Journal on Addictions · doi:10.1111/ajad.13305 · Cited by 13
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice
Margiani, G., Castelli, M. P., Pintori, N., Frau, R., Ennas, M. G., Zottola, A. C. P., Orrù, V., Serra, V., Fiorillo, E., Fadda, P., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06191-9 · Cited by 13
An Unconventional Gabaergic Circuit Differently Controls Pyramidal Neuron Activity in Two Visual Cortical Areas Via Endocannabinoids
Koukouli, F., Montmerle, M., Aguirre, A., van Velze, M. D. B., Peixoto, J., Choudhary, V., Varilh, M., Julio‐Kalajzić, F., Allène, C., Méndez, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2022.111202 · Cited by 12
Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain
Murray, C. J., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119552 · Cited by 12
The endocannabinoid system and breathing
Wiese, B. M., Reyes, A. A., Vanderah, T. W., & Largent‐Milnes, T. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1126004 · Cited by 12
Cannabinoid receptor gene CNR1 is downregulated in subcortical brain samples and upregulated in blood samples of individuals with schizophrenia: A participant data systematic meta‐analysis
Priel, S. B., Yitzhaky, A., Gurwitz, D., & Hertzberg, L. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16122 · Cited by 12
Therapeutic Targeting of Peripheral Cannabinoid Receptors in Inflammatory and Neuropathic Pain States
Spigelman, I. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c5 · Cited by 12
Exploring the versatile roles of the endocannabinoid system and phytocannabinoids in modulating bacterial infections
Barker, H., & Ferraro, M. J. (2024) · Infection and Immunity · doi:10.1128/iai.00020-24 · Cited by 11
THC Exposure is Reflected in the Microstructure of the Cerebral Cortex and Amygdala of Young Adults
Cabeen, R. P., Allman, J. M., & Toga, A. W. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa087 · Cited by 13
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB 2 receptor
Patel, M., Grimsey, N. L., Banister, S. D., Finlay, D. B., & Glass, M. (2023) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1157 · Cited by 11
Self-citation
Synthetic Cannabinoids: The Dangers of Spicing It Up
Salani, D. A., & Zdanowicz, M. M. (2015) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20150422-01 · Cited by 11
Medicinal uses of Cannabis sp.
de Souza, A. A. F., da Silva, A. F. M., de Abreu, L. R., da Silva, T. F., Greco, G. L. C., Santos, S. D. S., & Gonzaga, R. V. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16930 · Cited by 11
Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex
Ho, W. ‐. V., Patel, S., Thompson, J., Roberts, C. J., Stuhr, K. L., & Hillard, C. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00772.x · Cited by 11
Cannabis dependence: Effects of cannabis consumption on inter-regional cerebral metabolic relationships in an Indian population
Parkar, S., Ramanathan, S., Nair, N., Batra, S., Adarkar, S. A., Pandit, A., Kund, P., & Baghel, N. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.70976 · Cited by 11
Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex
Sim‐Selley, L. J., Vogt, L. J., Vogt, B. A., & Childers, S. R. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02017-9 · Cited by 11
Cannabinoids and value-based decision making: Implications for neurodegenerative disorders
Lee, A. M., Oleson, E. B., Diergaarde, L., Cheer, J. F., & Pattij, T. (2012) · Basal Ganglia · doi:10.1016/j.baga.2012.06.005 · Cited by 11
PET Imaging of Endocannabinoid System
Horti, A. G., Raymont, V., & Terry, G. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_11 · Cited by 11
CB1R mediates oleamide’s reward while 5HT2cR mediates aversion in the nucleus accumbens shell of rats
Méndez‐Díaz, M., Belmont, O. A., Gonzalez, V. E., Ruiz‐Contreras, A. E., & Prospero-Garcia, O. E. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.05.033 · Cited by 11
Chronic Temporomandibular Joint Arthralgia
Milam, S. B. (2000) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/s1042-3699(20)30228-4 · Cited by 11
The origin of brain asymmetry and its psychotic reversal
Fritzsche, M. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00376-6 · Cited by 11
Aminergic receptors during the development of the human brain: the contribution of in vitro imaging techniques
del Olmo, E., & Pazos, Á. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00097-7 · Cited by 11
A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
Bhardwaj, A. K., Mills, L., Doyle, M., Sahid, A., Montebello, M., Monds, L., Arunogiri, S., Haber, P., Lorenzetti, V., Lubman, D. I., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05616-3 · Cited by 10
Hypothalamic cannabinoid signaling: Consequences for eating behavior
Lord, M. N., & Noble, E. E. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1251 · Cited by 10
Neural substrates underlying the negative impact of cannabinoid exposure during adolescence
Molla, H. M., & Tseng, K. Y. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172965 · Cited by 10
Cannabis during pregnancy: A way to transfer an impairment to later life
Motamedi, S., Amleshi, R. S., Javar, B. A., Shams, P., Kohlmeier, K. A., & Shabani, M. (2023) · Birth Defects Research · doi:10.1002/bdr2.2207 · Cited by 10
Heteromers Formed by GPR55 and Either Cannabinoid CB1 or CB2 Receptors Are Upregulated in the Prefrontal Cortex of Multiple Sclerosis Patients
Menéndez-Pérez, C., Rivas‐Santisteban, R., del Valle, E., Tolivia, J., Navarro, A., Franco, R., & Martínez‐Pinilla, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084176 · Cited by 11
The Endocannabinoid System: A New Player in the Neurochemical Control of Vestibular Function?
Smith, P. F., Ashton, J. C., & Darlington, C. L. (2006) · Audiology and Neurotology · doi:10.1159/000092588 · Cited by 10
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
Wong, D. F., Kuwabara, H., Horti, A. G., Raymont, V., Brašić, J. R., Guevara, M. C., Nandi, A., Rahmim, A., Ming, J. E., & Cascella, N. G. (2010) · Journal of Nuclear Medicine · Cited by 10
Relationship between fMRI response during a nonverbal memory task and marijuana use in college students
Dager, A. D., Tice, M., Book, G. A., Tennen, H. A., Raskin, S. A., Austad, C. S., Wood, R. M., Fallahi, C. R., Hawkins, K. A., & Pearlson, G. D. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.03.025 · Cited by 10
Marijuana and the hippocampus: A longitudinal study on the effects of marijuana on hippocampal subfields
Garimella, A. H., Rajguru, S., Singla, U. K., & Alluri, V. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109897 · Cited by 10
Automated GMP production and long‐term experience in radiosynthesis of CB1 tracer [18F]FMPEP‐d2
Lahdenpohja, S., Keller, T., Forsback, S. J., Viljanen, T., Kokkomäki, E., Riikka, K., Bergman, J., Solin, O. H., & Kirjavainen, A. K. (2020) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3845 · Cited by 10
In Vitro and In Silico Characterization of G-Protein Coupled Receptor (GPCR) Targets of Phlorofucofuroeckol-A and Dieckol
Paudel, P., Seong, S. H., Park, S. E., Ryu, J. H., Jung, H. A., & Choi, J. S. (2021) · Marine Drugs · doi:10.3390/md19060326 · Cited by 10
Evidence Lacking for Cannabis Users Slacking: A Longitudinal Analysis of Escalating Cannabis Use and Motivation among Adolescents
Pacheco‐Colón, I., Hawes, S. W., Duperrouzel, J. C., & González, R. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s135561772000096x · Cited by 10
Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention
Scuderi, C., & Golini, L. (2021) · Animals · doi:10.3390/ani11092584 · Cited by 14
CEREBELLAR GREY MATTER DEFICITS, CANNABIS USE AND FIRST-EPISODE SCHIZOPHRENIA IN ADOLESCENTS AND YOUNG ADULTS
Cohen, M., Rasser, P. E., Peck, G., Carr, V. J., Ward, P. B., Thompson, P. M., Johnston, P., Baker, A., & Schall, U. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.251 · Cited by 10
Pharmacognosy and Effects of Cannabinoids in the Vascular System
Mensah, E., Tabrizchi, R., & Daneshtalab, N. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00141 · Cited by 12
Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat
Parker, K. E., McCall, J. G., McGuirk, S. R., Trivedi, S., Miller, D. K., & Will, M. J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.010 · Cited by 10
Exercise and Mood: Exploring the Role of Exercise in Regulating Stress Reactivity in Bipolar Disorder
Edenfield, T. M. (2007) · DigitalCommons (California Polytechnic State University) · Cited by 10
Cannabinoïdes et thérapeutique
Fabresse, N., Becam, J., Carrara, L., Descoeur, J., Mario, M. D., Drevin, G., Duval, T., Hannas, N., Lanot, T., Marillier, M., et al. (2019) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2019.06.002 · Cited by 10
Control of exploration, motor coordination and amphetamine sensitization by cannabinoid CB 1 receptors expressed in medium spiny neurons
Bonm, A. V., Elezgarai, I., Gremel, C. M., Viray, K., Bamford, N. S., Palmiter, R. D., Grandes, P., Lovinger, D. M., & Stella, N. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15381 · Cited by 12
Diverse chemotypes drive biased signaling by cannabinoid receptorsPreprint
Miljuš, T., Heydenreich, F. M., Gazzi, T., Kimbara, A., Rogers‐Evans, M., Nettekoven, M. H., Zirwes, E. A., Osterwald, A., Rufer, A. C., Ullmer, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.09.375162 · Cited by 10

Authors: Glass, M., Faull, R. L. M., & Dragunow, M.
Affiliations: University of Auckland (NZ)
Corresponding author: Faull, R.L.M
ORCID: Glass, M
Faull, R.L.M
Dragunow, M
Venue: Neuroscience
Publisher: Elsevier BV
Published: 1997-02
Volume: 77
Issue: 2
Pages: 299-318
ISSN: 0306-4522 (ISSN-L)
DOI: 10.1016/s0306-4522(96)00428-9
OpenAlex: W2037811574
Cited by: 1,052
References: 68
Citations by year: 2026: 28 · 2025: 40 · 2024: 34 · 2023: 39 · 2022: 56 · 2021: 53 · 2020: 52 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 42
FWCI: 11.26
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Keywords: cannabinoid receptors, human brain, receptor distribution, receptor density, fetal brain, neonatal brain, hippocampal formation, neocortex, cortical laminar organization, thalamus, basal ganglia, midbrain, spinal cord, globus pallidus internus, globus pallidus externus, ventral pallidum, striatum, amygdala, entorhinal cortex, hemispheric lateralization, CP55,940
MeSH terms: Adult, Aged, Aged, 80 and over, Autoradiography, Brain, Brain Chemistry, Brain Mapping, Cannabinoids, Coloring Agents, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myelin Sheath, Pregnancy, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks